With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?
- DOI
- 10.1093/rap/rkag139
- Published
- 2026
- Container
- Rheumatology advances in practice
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/rap/rkag139,
title = {With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?},
author = {Syrimi Z and McLaren Z and Moots RJ and Mewar D and Benson R},
year = {2026},
journal = {Rheumatology advances in practice},
doi = {10.1093/rap/rkag139},
url = {https://doi.org/10.1093/rap/rkag139}
}RIS
TY - JOUR TI - With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete? AU - Syrimi Z AU - McLaren Z AU - Moots RJ AU - Mewar D AU - Benson R PY - 2026 JO - Rheumatology advances in practice DO - 10.1093/rap/rkag139 UR - https://doi.org/10.1093/rap/rkag139 ER -
APA
Z, S., Z, M., RJ, M., D, M., & R, B. (2026). With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?. Rheumatology advances in practice. https://doi.org/10.1093/rap/rkag139
Source records
- pubmed · retrieved 2026-11-10T12:34:04.389Z